🔗 Share this article

An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these accounts directly for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on messaging services, where communities with thousands of members share comparison photos, injection guides and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Express Worries

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.

Some professionals stated the popularity for the experimental drug could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Platform Reaction and Material Elimination

Based on the social media company, the service has taken down problematic material and banned related hashtags and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in strengthening compliance measures.

Online Trading Operations

Research also discovered communities with up to nine thousand participants marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at home.

Within moments of entering one group, a seller shared contact information, where the majority of transactions occur. The seller sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, messages display dark colored packages with postal service labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens typically sold at £160 for 20mg. When questioned how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are injecting substances they can’t verify. Even if the science behind this drug is valid, these digital products may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in interest to current price rises for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has already seen patients harmed by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject patients to potentially significant medical dangers”.